Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The invertebrate L-glutamate-gated chloride channel (GluCl) is a member of the Cys-loop family of ligand-gated ion channels, found exclusively in protostome invertebrates such as nematodes and arthropods (Wolstenholme, 2012). It mediates fast inhibitory neurotransmission by allowing the influx of chloride ions upon activation by L-glutamate, leading to membrane hyperpolarization and suppression of electrical activity (Hibbs & Gouaux, 2011). Because GluCls are absent in vertebrates, they serve as a critical selective target for several classes of antiparasitic drugs and insecticides, providing a high therapeutic index (Cully et al., 1994). Macrocyclic lactones, such as ivermectin, bind allosterically to these channels to cause prolonged opening, which results in the flaccid paralysis and death of parasites like heartworms and lice (AOPWiki, AOP113). Other compounds, including fipronil and the isoxazoline class, target these channels as antagonists to disrupt the nervous system of ectoparasites. Understanding GluCl structure and function is essential for managing parasitic diseases in veterinary and human medicine and for addressing the growing challenge of drug resistance in global health (UniProtKB, G5EBR3).
Macrocyclic lactones (e.g., ivermectin) act as potent positive allosteric modulators and agonists that bind to the transmembrane domain of the channel, stabilizing the open state and leading to persistent chloride influx, hyperpolarization, and flaccid paralysis of the parasite (Hibbs & Gouaux, 2011; Wolstenholme, 2012). Conversely, phenylpyrazoles (e.g., fipronil) and isoxazolines (e.g., afoxolaner) act as non-competitive antagonists that block the channel pore, causing hyperexcitation and death (Casida & Durkin, 2013).
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Invertebrate L-glutamate-gated chloride channel (GluCl).